Business Wire

SEKISUI-HOUSE

30.11.2021 15:02:59 CET | Business Wire | Press release

Share
Sekisui House, Ltd.: Working With Customers for 20 Years to Conserve Urban Biodiversity With the Gohon no ki Indigenous Landscaping Concept

Sekisui House, Ltd. (TOKYO:1928) has been pursuing the conservation of biodiversity since 2001 by creating green networks in urban residential districts under its Gohon no ki (“five trees”) indigenous landscaping concept. Together with the University of the Ryukyus1 , the company has analyzed the outcome of the Gohon no ki Project that it has implemented with 1 million customer households2 over the space of 20 years, and has designed the world’s first mechanism for quantitatively evaluating urban biodiversity. It has published this qualitative evaluation mechanism today as a nature-positive methodology for promoting the conservation of biodiversity.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211130005350/en/

The Gohon no ki Project

Since the 1970s, incessant urban development has dramatically reduced the amount of habitat available for flora and fauna in our cities. Sekisui House launched its Gohon no ki Project in 2001 as an initiative to conserve biodiversity through the eco-friendly landscaping and greening of the gardens of its customers. Based on the concept of planting five locally native trees, three for birds and two for butterflies, the Gohon no ki Project proposes greening gardens and local communities with native tree species suited to the local climate and benevolent to birds, butterflies, and other local fauna. The project takes its lead from garden landscaping modeled on traditional Japanese satoyama (which translates roughly as “village woodland”).

In the 20 years from 2001 up to 2020, more than 17 million trees have been planted under the project. The company has also promoted urban greening throughout Japan by incorporating the Gohon no ki concept into its planning of green spaces in its condominium and community development initiatives.

Quantitative evaluation of biodiversity

Sekisui House has since 2019 been working with the Kubota Laboratory, Faculty of Science, University of the Ryukyus, and Think Nature Inc. to quantitatively evaluate the contribution of this network-type greening to urban biodiversity. Based on the Japan Biodiversity Mapping Project (J-BMP)3 managed and operated by Think Nature Inc., a company established by Professor Yasuhiro Kubota, the partners have analyzed the data on tree number, species, and location accumulated over the 20 years of the Sekisui House Gohon no ki Project to quantitatively evaluate the effectiveness of the project in conserving and restoring biodiversity.

This quantitative evaluation revealed the following benefits for biodiversity from planting native tree species in line with the Gohon no ki Project as opposed to planting conventional horticultural and exotic species in gardens in urban areas where biodiversity has declined significantly (Japan’s three major metropolitan areas).4

  • The number of native tree species in each region—the foundation of regional biodiversity—has increased tenfold.
  • The number of bird species that residential districts can attract has doubled.
  • The number of butterfly species that residential districts can attract has increased fivefold.
  • Biodiversity in the three metropolitan areas has recovered to 30% of the level of 1977 for which the first trustworthy biodiversity related data exists.

This is the world’s first mechanism for quantitatively evaluating urban biodiversity and its application to an actual case. The disclosure of numerical data enables biodiversity to be expressed in terms of financial value, thereby providing a means for visualizing private sector contribution to biodiversity.

Nature-positive methodology

In recent years, increasing efforts are being made to conserve biodiversity. In June of this year, the Taskforce on Nature-related Financial Disclosures (TNFD) was launched, and in October, the 15th Conference of the Parties to the Convention on Biological Diversity (COP15) was held. In Japan too, discussion has begun in earnest on other effective area-based conservation measures (OECMs) for enlisting the support of the private sector to drive urban greening.

In this societal context, Sekisui House is making its 20-year biodiversity conservation initiative available to the public as a nature-positive methodology. The Gohon no ki Project’s nature-positive methodology represents a means for expressing urban biodiversity. Sekisui House is making this methodology available to the general public with the aim of raising awareness and enabling its store of knowledge and expertise to be utilized by others to promote greening and contribute to the conservation of biodiversity.

Nature-positive methodology website
https://www.sekisuihouse.co.jp/gohon_sp/method/

Predicted benefits

Based on joint review of available data, Sekisui House and its partners set the number of tree, bird, and butterfly species, diversity index, and number of individual trees, birds, and butterflies in 1977 as 100%, and using 2000, the year before the Gohon no ki Project was launched, as the base year, simulated change up to 2070 in Japan’s three largest metropolitan areas (Kanto, Kinki and Chukyo) that have suffered the greatest decline in biodiversity. This simulation indicated that planting native tree species that are likely to benefit local fauna (the Gohon no ki concept) compared to 2000, the year before the launch of the Gohon no ki Project, would enable biodiversity to recover to 37.4% of 1977 levels by 2030 (target year for conservation of biodiversity internationally), 40.9% by 2050, and 41.9% by 2070.

If the Gohon no ki concept of planting native trees were applied to 30% of all newly constructed properties in Japan moving forward, urban biodiversity is predicted to rise to 84.6% of 1977 levels. Sekisui House believes that this indicates that if the private sector works with the general public, the decline in biodiversity can be reversed to achieve the goal of post-2020 biodiversity recovery that is the theme of COP15, and that its Gohon no ki concept can contribute to this goal.

We've received comments of endorsement from the following people. For more details, please refer to the attached document or the original news release via your browser.
https://www.sekisuihouse.co.jp/english/company/release/topics_2021/20211126_en/

  • Mr. Makoto Haraguchi, Fellow, MS & AD InterRisk Research Institute and Sustainability Section SVP for TNFD, MS & AD Insurance Group Holdings
  • Mr. Teppei Dohke, Executive Secretary General of the Japan Committee for the International Union for Conservation of Nature
  • Ms. Mariko Kawaguchi, Specially Appointed Professor, Rikkyo University / Executive Advisor to CEO, Fuji Oil Holdings Inc.
  • Mr. Yasuhiro Kubota, Professor, Faculty of Science, University of the Ryukyus / Representative Director, Think Nature Inc.

1. This is joint research with the Kubota Laboratory, Faculty of Science, University of the Ryukyus.
2. Cumulative number of households built from February 2001 to January 2021 is 1,001,977.
3. Japan Biodiversity Mapping Project (J-BMP) website: https://biodiversity-map.thinknature-japan.com
4. Comparison of continuing to plant conventional garden tree species with planting tree species in line with the Gohon no ki concept over the 20 years from 2001 to 2020

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release

Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P

Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release

Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result

Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release

Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said

SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release

In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin

Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release

Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye